Supriya Lifescience Leaders Honoured at Avendus Wealth–Hurun India U40 Awards 2025

February 5, 2026: Supriya Lifescience Ltd., a leading Indian manufacturer of Active Pharmaceutical Ingredients (APIs), announced that its senior leaders have received a major national honour. Dr. Saloni Wagh, Managing Director, and Shivani Wagh, Joint Managing Director, were honoured at the Avendus Wealth – Hurun India U40 Awards 2025. The awards ceremony took place at the Four Seasons Hotel in Mumbai on January 29, 2026.

Celebrating India’s Most Promising Entrepreneurs Under 40

The Avendus Wealth–Hurun India U40 Awards recognise young entrepreneurs who build high-impact businesses with scale, innovation, and purpose. Moreover, the platform highlights founders and next-generation leaders who strengthen India’s entrepreneurial ecosystem and expand the country’s global business influence.

This recognition places Dr. Saloni Wagh and Shivani Wagh among India’s most influential young business leaders.

Leadership That Strengthens Supriya Lifescience’s Global Footprint

The leadership of Dr. Saloni Wagh and Shivani Wagh has played a key role in Supriya Lifescience’s steady growth. Over the years, the company has focused on business continuity, global expansion, and improved access to quality healthcare.

At the same time, Supriya Lifescience has reinforced its commitment to sustainable growth, strong governance, and long-term value creation. As a result, the company continues to strengthen its presence in international pharmaceutical markets.

Dr. Saloni Wagh on Responsible and Innovation-Led Growth

Speaking on the honour, Dr. Saloni Wagh said the recognition reflects collective effort and long-term vision.

She noted that being recognised by the Avendus Wealth–Hurun India platform marks an important milestone. According to her, the award highlights the company’s focus on building a globally competitive, innovation-driven pharmaceutical business from India. She also emphasised the importance of responsible leadership and sustainable value creation.

Shivani Wagh on Purpose-Driven Scale and Global Healthcare Access

Sharing her thoughts, Shivani Wagh described the platform as a strong celebration of ambition and impact. She added that Indian entrepreneurs today are building faster and bolder businesses.

She further said that the recognition strengthens Supriya Lifescience’s commitment to operational excellence, sustainability, and expanding access to healthcare across global markets.

Continued Industry Recognition for Supriya Lifescience Leadership

This honour adds to a growing list of recognitions for Dr. Saloni Wagh and Shivani Wagh. In 2025, both leaders were featured by Hurun India for their contributions to the pharmaceutical sector.

Under their leadership, Supriya Lifescience continues to expand its global reach while reinforcing India’s position in the international API manufacturing landscape.

Also Read : Capacit’e Infraprojects Receives ₹445 Crore LOI from Great Value Realty